These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24103019)

  • 1. Evaluation of the performance of the microscopic observation drug susceptibility assay for diagnosis of extrapulmonary tuberculosis in China: A preliminary study.
    Huang Z; Xiong G; Luo Q; Jiang B; Li W; Xu X; Li J
    Respirology; 2014 Jan; 19(1):132-7. PubMed ID: 24103019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.
    Lazarus RP; Kalaiselvan S; John KR; Michael JS
    Indian J Med Microbiol; 2012; 30(1):64-8. PubMed ID: 22361763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
    Shiferaw G; Woldeamanuel Y; Gebeyehu M; Girmachew F; Demessie D; Lemma E
    J Clin Microbiol; 2007 Apr; 45(4):1093-7. PubMed ID: 17251409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia.
    Lora MH; Reimer-McAtee MJ; Gilman RH; Lozano D; Saravia R; Pajuelo M; Bern C; Castro R; Espinoza M; Vallejo M; Solano M; Challapa R; Torrico F
    BMC Infect Dis; 2015 Jun; 15():222. PubMed ID: 26047953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum].
    Lu JM; Wang J; Huang XC; Hu ZY; Cui ZL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):21-5. PubMed ID: 21418814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.
    Rasslan O; Hafez SF; Hashem M; Ahmed OI; Faramawy MA; Khater WS; Saleh DA; Mohamed MI; Khalifa MA; Shoukry FA; El-Moghazy EH
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):941-6. PubMed ID: 22584201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.
    Moore DA; Mendoza D; Gilman RH; Evans CA; Hollm Delgado MG; Guerra J; Caviedes L; Vargas D; Ticona E; Ortiz J; Soto G; Serpa J;
    J Clin Microbiol; 2004 Oct; 42(10):4432-7. PubMed ID: 15472289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid and low-cost microscopic observation drug susceptibility assay for detecting TB and MDR-TB among individuals infected by HIV in South India.
    Solomon S; Balakrishnan P; Vignesh R; Waldrop G; Solomon SS; Murugavel KG; Kumarasamy N; Yepthomi T; Poongulali S; Swathirajan CR; Sreenivasan V; Chandrasekar C; Suriakumar J; Mahilmaran A; Manoharan G; Moore DA
    Indian J Med Microbiol; 2013; 31(2):130-7. PubMed ID: 23867668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis.
    Huang ZK; Luo Q; Jiang BX; Li WT; Xu XM; Xiong GL; Li JM
    Chin Med J (Engl); 2013 Nov; 126(22):4334-9. PubMed ID: 24238524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
    Arias M; Mello FC; Pavón A; Marsico AG; Alvarado-Gálvez C; Rosales S; Pessôa CL; Pérez M; Andrade MK; Kritski AL; Fonseca LS; Chaisson RE; Kimerling ME; Dorman SE
    Clin Infect Dis; 2007 Mar; 44(5):674-80. PubMed ID: 17278058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria.
    Ochang EA; Oduyebo OO; Onwuezobe IA; Collier D; Bode-Sojobi I; Odo M
    Niger J Med; 2016; 25(3):226-33. PubMed ID: 30011167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MODS assay for rapid detection of Mycobacterium tuberculosis resistance to second-line drugs in a tertiary care tuberculosis hospital in China.
    Huang Z; Li G; Chen J; Li W; Xu X; Luo Q; Xiong G; Sun J; Li J
    Tuberculosis (Edinb); 2014 Sep; 94(5):506-10. PubMed ID: 25082461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
    Sanogo M; Kone B; Diarra B; Maiga M; Baya B; Somboro AM; Sarro YS; Togo ACG; Dembele BPP; Goita D; Kone A; M'Baye O; Coulibaly N; Diabate S; Traore B; Diallo MH; Coulibaly YI; Saleeb P; Belson M; Orsega S; Siddiqui S; Polis MA; Dao S; Murphy RL; Diallo S
    Clin Microbiol Infect; 2017 Jun; 23(6):408.e1-408.e6. PubMed ID: 28110049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
    Ejigu GS; Woldeamanuel Y; Shah NS; Gebyehu M; Selassie A; Lemma E
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):332-7. PubMed ID: 18284841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.
    Makamure B; Mhaka J; Makumbirofa S; Mutetwa R; Mupfumi L; Mason P; Metcalfe JZ
    PLoS One; 2013; 8(2):e55872. PubMed ID: 23409072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis.
    Minion J; Leung E; Menzies D; Pai M
    Lancet Infect Dis; 2010 Oct; 10(10):688-98. PubMed ID: 20813587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis.
    Dixit P; Singh U; Sharma P; Jain A
    J Microbiol Methods; 2012 Jan; 88(1):122-6. PubMed ID: 22133919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.